CD19 CAR-T cells expressing this chimeric receptor demonstrated enhanced proliferation and cytokine polyfunctionality compared to control CAR-T cells in xenograft models of NALM6 human leukemia cells and subcutaneous CD19+ tumors, suggesting a key role for STAT3 in suppressing terminal differentiation of T cells (223–225). The gene discussed is CD19; the disease is leukemia.